CHESTONE TABLETS

Indications

• Cough
• Bronchitis
• Asthma
• Respiratory tract infections
• Inflammatory conditions

Dosage

Children: Refer to established guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The primary active components of Adhatoda, particularly vasicine and vasicinone, exhibit bronchodilator effects by relaxing the bronchial smooth muscles. They also act as mucolytics, facilitating the clearance of mucus from the respiratory tract. Furthermore, these compounds have been shown to exert anti-inflammatory effects by inhibiting the release of pro-inflammatory cytokines and mediators. This multi-faceted mechanism makes Adhatoda effective in alleviating symptoms associated with respiratory ailments.

Pharmacodynamics

Adhatoda demonstrates a range of pharmacodynamic effects, including bronchodilation, mucus secretion modulation, and anti-inflammatory action. The alkaloids enhance ciliary action in the respiratory tract, improving mucus clearance. The anti-inflammatory properties reduce airway inflammation, which is beneficial in conditions such as asthma and chronic bronchitis. Additionally, the antimicrobial activity of Adhatoda may help in preventing secondary infections in respiratory diseases.

Pharmacokinetics

The pharmacokinetics of Adhatoda have not been extensively studied. However, it is known that the active compounds are absorbed after oral administration, with effects typically observed within hours. The metabolic pathways of vasicine and other alkaloids involve hepatic metabolism, and they are likely excreted in urine. The bioavailability and half-life of these compounds require further investigation to establish precise pharmacokinetic profiles.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Dizziness
• Headache
• Skin rash

Interactions

• May interact with anticoagulants, increasing the risk of bleeding
• Potential interaction with antihypertensive medications

Precautions

• Use with caution in patients with a history of gastrointestinal disorders
• Should be used cautiously in patients with liver disease
• Monitor for potential allergic reactions

Pregnancy

Ahdatoda should be used cautiously during pregnancy. Consultation with a healthcare provider is recommended.

Breast-feeding

Safety during breastfeeding has not been established; consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Dried leaves
• Powdered form
• Extracts

Indications

• Type 2 diabetes mellitus
• Metabolic syndrome
• Dyslipidemia
• Inflammatory disorders
• Antioxidant support

Dosage

Children: Refer to established guidelines for specific dosing; pediatric use is not well standardized and should be approached with caution.

Adults: Refer to established guidelines for specific dosing; typically, doses range from 1 to 6 grams of cinnamon powder per day.

Mechanism of action

Cinnamon contains bioactive compounds such as cinnamaldehyde, which may enhance insulin sensitivity and improve glucose uptake in cells. It may also exert antioxidant effects and reduce inflammation by modulating various signaling pathways, including the NF-kB pathway.

Pharmacodynamics

The pharmacodynamic effects of cinnamon include modulation of glucose and lipid metabolism, anti-inflammatory effects, and antioxidant activity. Cinnamaldehyde has been shown to activate insulin signaling pathways, thereby improving insulin sensitivity. Additionally, cinnamon may influence the expression of genes involved in glucose metabolism.

Pharmacokinetics

Cinnamon is generally well absorbed when ingested. The bioavailability of its active compounds can vary based on the formulation and method of consumption. Metabolism occurs in the liver, where compounds such as cinnamaldehyde may be transformed into various metabolites. The elimination half-life of cinnamon's active components is not well defined but is expected to vary among individuals.

Adverse effects

• Allergic reactions
• Skin irritation
• Gastrointestinal upset

Interactions

• May enhance the effects of anticoagulants
• Potential interaction with antidiabetic medications

Precautions

• Use with caution in individuals with known allergies to cinnamon or related species
• Monitor blood glucose levels in diabetic patients

Pregnancy

Cinnamon is generally considered safe in food amounts, but high doses should be avoided.

Breast-feeding

Cinnamon in food amounts is likely safe, but high doses should be avoided.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Cinnamon powder
• Cinnamon oil
• Cinnamon extract

Indications

• Metabolic acidosis
• Renal insufficiency
• Chronic kidney disease
• Management of urinary calculi
• As an adjunct in certain chemotherapy regimens

Dosage

Children: Refer to pediatric dosing guidelines and consult with a clinician for appropriate dosing based on the child’s age, weight, and clinical condition.

Adults: Refer to established guidelines and consult with a clinician for appropriate dosing based on the specific clinical scenario.

Mechanism of action

Citras acts by increasing the levels of bicarbonate in the blood, which helps to neutralize excess acids. The citrate is metabolized in the liver to bicarbonate, thereby serving as a substrate for gluconeogenesis and enhancing the buffering capacity of blood, which alleviates acidosis.

Pharmacodynamics

The alkalinizing effect of citras helps maintain acid-base homeostasis. By increasing serum bicarbonate levels, it can improve symptoms related to acidosis, including fatigue, confusion, and respiratory distress. The onset of action generally occurs within hours, with the duration of effect depending on the dose and individual metabolic response.

Pharmacokinetics

Citras is usually administered orally and is well absorbed in the gastrointestinal tract. It undergoes hepatic metabolism, where it is converted into bicarbonate. The elimination of citrate primarily occurs through renal excretion, where the kidneys play a crucial role in maintaining systemic acid-base balance. The half-life of citrate in the body may vary based on individual renal function.

Pregnancy

Use with caution. Consult a healthcare provider before use.

Breast-feeding

Use with caution. Consult a healthcare provider before use.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Respiratory infections
• Cough and cold symptoms
• Sinusitis
• Bronchitis
• Muscle pain and inflammation

Dosage

Children: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing of eucalyptus oil in children, as it varies based on formulation and indication.

Adults: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing of eucalyptus oil, as it varies based on formulation and indication.

Mechanism of action

Eucalyptus oil contains compounds such as eucalyptol (1,8-cineole) that exhibit antimicrobial properties. It acts on the respiratory system by promoting bronchodilation and reducing mucus production. The oil also has a cooling effect, which can provide relief from symptoms of respiratory distress. Additionally, the oil's anti-inflammatory properties help decrease inflammation in the airways.

Pharmacodynamics

The primary active ingredient in eucalyptus oil, eucalyptol, interacts with the body's inflammatory response and can modulate the activity of neurotransmitters involved in pain signaling. It may enhance mucociliary clearance in the respiratory tract, facilitating the expulsion of mucus and pathogens. The analgesic effects can help relieve discomfort associated with respiratory infections.

Pharmacokinetics

Eucalyptus oil is typically administered via inhalation or topical application. When inhaled, components like eucalyptol are absorbed through the mucous membranes of the respiratory tract and rapidly distributed throughout the body. The oil is metabolized primarily in the liver, and its metabolites are excreted in urine. The half-life of eucalyptol varies but is generally short, necessitating frequent dosing for sustained effects.

Adverse effects

• Allergic reactions
• Skin irritation
• Nausea
• Vomiting
• Diarrhea
• Dizziness

Interactions

• May interact with anticoagulants, potentially increasing bleeding risk
• May enhance the effects of other medications that cause sedation

Precautions

• Use with caution in individuals with asthma or other respiratory conditions
• Avoid use in young children without medical supervision
• Eucalyptus oil should not be ingested in large quantities due to toxicity

Pregnancy

Eucalyptus oil is generally considered unsafe in pregnancy due to potential toxicity and should be avoided unless prescribed by a healthcare professional.

Breast-feeding

Caution is advised when using eucalyptus during breastfeeding, as it may pass into breast milk and could affect the infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Eucalyptus oil (topical, inhalation, or oral preparations)
• Eucalyptus leaves (dried for teas or extracts)

Indications

• Gastrointestinal disorders (e.g., peptic ulcers, dyspepsia)
• Respiratory conditions (e.g., cough, bronchitis)
• Inflammatory conditions (e.g., arthritis, dermatitis)
• Viral infections (e.g., hepatitis, herpes simplex)

Dosage

Children: Refer to established clinical guidelines for appropriate dosing, as no specific dose is provided.

Adults: Refer to established clinical guidelines for appropriate dosing, as no specific dose is provided.

Mechanism of action

Glycyrrhizin, the active compound in glabra, inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 2, leading to increased cortisol levels in tissues. This mechanism helps to reduce inflammation and modulate immune responses. Additionally, glabra exhibits antiviral activity by inhibiting the replication of certain viruses, possibly through interference with viral proteins and host cell interactions.

Pharmacodynamics

The pharmacodynamic effects of glabra are primarily attributed to glycyrrhizin and flavonoids present in the plant. Its anti-inflammatory effects are mediated through the inhibition of pro-inflammatory cytokines and pathways such as NF-κB. The compound also has expectorant properties, aiding in the relief of cough and respiratory distress by promoting mucus secretion and reducing irritation in the airways.

Pharmacokinetics

Glycyrrhizin is absorbed in the gastrointestinal tract, and its bioavailability can be influenced by the presence of other food components. Once absorbed, it undergoes hepatic metabolism, with its metabolites excreted primarily through urine. The half-life of glycyrrhizin can vary but is generally several hours, necessitating multiple doses for sustained therapeutic effects. Chronic use may lead to accumulation and potential side effects such as hypertension and hypokalemia due to its mineralocorticoid-like effects.

Pregnancy

The safety of glabra during pregnancy has not been established. It is advisable to avoid its use unless clearly needed.

Breast-feeding

There is limited information on the excretion of glabra in human milk. Caution is advised when administering to breastfeeding mothers.

Storage

Store at room temperature, away from moisture and direct light. Keep out of reach of children.

Indications

• Adrenal insufficiency
• Chronic inflammatory conditions

Mechanism of action

Glycyrrhizin, the primary active component of Glycyrrhiza, exerts its effects primarily through inhibition of the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2). This inhibition prevents the conversion of active cortisol to inactive cortisone, leading to increased cortisol levels. Elevated cortisol mimics the effects of aldosterone, resulting in sodium retention, potassium excretion, and increased blood pressure. Additionally, licorice has anti-inflammatory and antiviral properties attributed to its ability to modulate various immune pathways and inhibit viral replication.

Pharmacodynamics

The pharmacodynamic effects of Glycyrrhiza include anti-inflammatory, antiviral, and immunomodulatory activities. Glycyrrhizin has been shown to reduce inflammation by inhibiting the production of pro-inflammatory cytokines and mediators. Its potential antiviral properties are particularly noted in viral infections such as hepatitis C and COVID-19, where it may inhibit viral replication. Furthermore, its ability to enhance the effects of corticosteroids can be beneficial in treating conditions associated with adrenal insufficiency or chronic inflammation.

Pharmacokinetics

Glycyrrhizin is absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1-2 hours after oral administration. It undergoes extensive metabolism in the liver, primarily through conjugation processes, leading to the formation of glycyrrhetic acid as a major metabolite. The elimination half-life of glycyrrhizin is approximately 6-8 hours. Glycyrrhiza components are excreted in urine predominantly as conjugated forms. Long-term use can lead to accumulation and potential side effects due to its mineralocorticoid-like effects.

Contra-indications

• Hypertension
• Hypokalemia
• Severe kidney disease
• Pregnancy (due to hormonal effects)

Adverse effects

• Hypertension
• Hypokalemia
• Edema
• Headaches
• Fatigue
• Muscle weakness
• Cardiac arrhythmias (with excessive use)

Interactions

• May enhance the effects of corticosteroids
• May increase the risk of hypokalemia with diuretics
• May interact with anticoagulants, increasing the risk of bleeding
• May affect the metabolism of drugs metabolized by CYP3A4

Precautions

• Use with caution in patients with cardiovascular disease
• Monitor blood pressure and potassium levels during prolonged use
• Not recommended for long-term use without medical supervision

Pregnancy

Glycyrrhiza should be avoided during pregnancy as it may cause hormonal effects that could affect fetal development.

Breast-feeding

Consult a healthcare provider before use while breastfeeding, as safety is not well established.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Formulations

• Dried root
• Extracts (liquid and powdered)
• Teas
• Capsules

Indications

• Irritable bowel syndrome (IBS)
• Diarrhea
• Constipation
• Gut dysbiosis
• Support for immune function
• Enhancement of gut health

Dosage

Adults: Refer to specific product guidelines and consult a healthcare professional for dosing recommendations, as doses can vary based on formulation and intended

Mechanism of action

Bifidobacterium longum exerts its beneficial effects primarily through the modulation of the gut microbiota. It helps in the fermentation of dietary fibers, producing short-chain fatty acids (SCFAs) that nourish colon cells and maintain gut barrier integrity. Moreover, it competes for adhesion sites and nutrients against pathogenic bacteria, thereby inhibiting their growth. This strain also has immunomodulatory effects, enhancing the host's immune response by promoting the production of anti-inflammatory cytokines and increasing the activity of immune cells.

Pharmacodynamics

The pharmacodynamics of Bifidobacterium longum involve its ability to balance the gut microbiome, enhance mucosal immunity, and improve intestinal permeability. It has been shown to lower the pH of the gut, creating an unfavorable environment for pathogenic organisms. Additionally, it can alleviate symptoms associated with gastrointestinal disorders such as irritable bowel syndrome (IBS), diarrhea, and constipation by promoting regular bowel movements and reducing inflammation in the gut.

Pharmacokinetics

Bifidobacterium longum is not absorbed into the systemic circulation but acts locally within the gastrointestinal tract. Its effects are primarily exerted in the intestines, where it colonizes and interacts with the gut environment. The survival and efficacy of this probiotic can be influenced by factors such as the formulation, dosage, and the individual's existing gut microbiota. Generally, ingestion of probiotics leads to transient colonization, with the bacteria being excreted in feces within a few days after discontinuation of use.

Pregnancy

Safety during pregnancy has not been established. Consult healthcare professionals before use.

Breast-feeding

Safety during breastfeeding has not been established. Consult healthcare professionals before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Indications

• Topical analgesic for muscle and joint pain
• Cough suppressant in cough drops and lozenges
• Relief of minor throat irritation
• Cooling agent in various cosmetic and personal care products

Dosage

Children: Refer to BNF for Children for specific dosing guidelines, as doses may vary based on age and formulation.

Adults: For topical use, apply a thin layer to the affected area not more than 3 to 4 times daily. For cough drops, follow the product-specific instructions as per the formulation.

Mechanism of action

Menthol acts as an agonist for the transient receptor potential subtype M8 (TRPM8), a non-selective cation channel that is activated by cold temperatures. This activation leads to calcium influx in mast cells, inducing the release of histamine, which can trigger allergic responses such as urticaria, asthma, and rhinitis. Menthol's ability to induce histamine release via TRPM8 suggests potential therapeutic applications for TRPM8 antagonists in managing cold- and menthol-induced allergies.

Pharmacodynamics

Menthol produces a cooling effect by stimulating sensory neurons that convey cold sensations. It interacts with TRPM8 channels, leading to the activation of intracellular signaling pathways that can result in vasodilation and increased blood flow to the area of application. This cooling sensation can provide symptomatic relief in conditions characterized by pain or irritation.

Pharmacokinetics

Menthol is absorbed through the skin and mucous membranes, with systemic effects depending on the route of administration. Its bioavailability can vary, and it is metabolized primarily in the liver. The elimination half-life and excretion pathways have not been extensively characterized, but menthol is generally considered to have a rapid onset of action with effects lasting for a few hours.

Adverse effects

• Allergic reactions
• Urticaria
• Asthma
• Rhinitis
• Skin irritation

Precautions

• Use with caution in patients with known allergies to menthol or related compounds
• May exacerbate asthma in sensitive individuals

Pregnancy

There are no well-controlled studies of menthol in pregnant women. Menthol should be used during pregnancy only if clearly needed.

Breast-feeding

Menthol is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Topical ointment
• Cream
• Liquid

Indications

• Hyponatremia
• Dehydration
• Electrolyte replacement
• Fluid resuscitation

Dosage

Children: Refer to the BNF for Children for specific dosing based on the indication and age of the child.

Adults: Refer to clinical guidelines for specific dosing based on the indication and severity of condition.

Mechanism of action

Sodium ions (Na+) are actively transported across cell membranes via sodium-potassium ATPase pumps, which help maintain the electrochemical gradients essential for cellular function. In the kidneys, sodium reabsorption occurs primarily in the proximal tubule, loop of Henle, and distal convoluted tubule, contributing to the regulation of blood volume and pressure. Sodium also influences the secretion of hormones such as aldosterone, which further regulates sodium and water balance.

Pharmacodynamics

Sodium contributes to the generation and transmission of action potentials in neurons and muscle cells by maintaining the resting membrane potential. It is involved in the regulation of blood pressure through its effects on blood volume. Changes in sodium concentration can influence the secretion and activity of various hormones, including antidiuretic hormone (ADH) and aldosterone, thereby impacting fluid balance and electrolyte homeostasis.

Pharmacokinetics

Sodium is readily absorbed from the gastrointestinal tract, with peak plasma concentrations typically occurring within 30 minutes to 2 hours after ingestion. It is distributed throughout the extracellular fluid compartment and is excreted primarily via the kidneys. The renal handling of sodium is tightly regulated through mechanisms that involve glomerular filtration, tubular reabsorption, and hormonal control, particularly by aldosterone.

Contra-indications

• Hypersensitivity to natrii or any of its components
• Severe renal impairment
• Hypernatremia

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Headache
• Dizziness
• Fluid retention
• Hypertension
• Edema

Interactions

• Diuretics may enhance the risk of electrolyte imbalance
• Corticosteroids may exacerbate fluid retention and hypertension
• ACE inhibitors may lead to hyperkalemia when combined with natrii

Precautions

• Use with caution in patients with cardiovascular disease
• Monitor sodium levels in patients with renal impairment
• Consider adjusting dosage in elderly patients

Pregnancy

Natrii should be used during pregnancy only if clearly needed, as it can affect fluid balance.

Breast-feeding

Natrii is excreted in breast milk, caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral tablets
• Injectable solutions
• Sodium chloride solutions for intravenous administration

Indications

• Stress relief
• Reproductive health enhancement
• Lactation support
• Immunity boosting
• Overall vitality improvement

Dosage

Children: Refer to established herbal guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established herbal guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The exact mechanism of action of navasadara is not fully understood. However, it is believed to exert its effects through the modulation of the hypothalamic-pituitary-adrenal (HPA) axis, which plays a crucial role in stress response. Navasadara may also enhance the synthesis and secretion of hormones such as progesterone, potentially aiding reproductive functions. Its antioxidant properties contribute to reducing oxidative stress, thereby promoting overall health.

Pharmacodynamics

Navasadara exhibits adaptogenic properties, meaning it helps the body adapt to stress and maintain homeostasis. It is thought to influence various physiological processes, including hormonal balance and immune function. The herb has been reported to possess anti-inflammatory, immunomodulatory, and antioxidant effects, which may contribute to its health benefits.

Pharmacokinetics

The pharmacokinetics of navasadara, including its absorption, distribution, metabolism, and excretion, are not well-documented in the literature. However, like many herbal compounds, its bioactive constituents are likely to be absorbed in the gastrointestinal tract. The extent and rate of absorption may vary based on the formulation and presence of other compounds in herbal preparations. Further research is needed to fully elucidate its pharmacokinetic profile.

Pregnancy

Safety during pregnancy has not been established. Use with caution and only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known if navasadara is excreted in human milk. Caution should be exercised when administered to a nursing mother.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Gastrointestinal disorders
• Respiratory issues
• Anti-inflammatory treatment
• Pain relief
• Antioxidant support

Dosage

Children: Due to the potential toxicity of certain parts of the nigrum plant, pediatric dosing should be approached with caution and under medical supervision. It is recommended to refer to established pediatric guidelines for specific dosing information.

Adults: Dosing for nigrum varies depending on the preparation and specific condition being treated. Generally, it is advised to consult with a healthcare professional for appropriate dosing based on individual needs.

Mechanism of action

Nigrum contains several bioactive compounds, including alkaloids, glycosides, and flavonoids. These compounds are believed to exert their effects through various biochemical pathways, including modulation of neurotransmitter activity, inhibition of inflammatory cytokines, and antioxidant activity, which may contribute to its therapeutic properties.

Pharmacodynamics

The pharmacodynamic effects of nigrum are primarily due to its active constituents that interact with various receptors and enzymes in the body. The anti-inflammatory properties are thought to arise from the inhibition of cyclooxygenase (COX) enzymes and the modulation of nitric oxide production. Additionally, nigrum may have analgesic and sedative effects, attributed to its interaction with the central nervous system.

Pharmacokinetics

The pharmacokinetics of nigrum have not been extensively studied. However, it is known that the bioavailability of plant extracts can vary based on the method of preparation and individual metabolism. Generally, the absorption, distribution, metabolism, and excretion of its active compounds will depend on factors such as the specific preparation used and the individual's physiological characteristics.

Pregnancy

The safety of nigrum during pregnancy has not been established. Use with caution and only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether nigrum is excreted in human milk. Caution is advised when administering to breastfeeding mothers.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Digestive disorders
• Respiratory conditions
• Antimicrobial therapy
• Anti-inflammatory support
• Stress relief

Dosage

Children: Refer to specific herbal preparation guidelines; there is no standard paediatric dose for Ocimum.

Adults: Refer to specific herbal preparation guidelines; there is no standard adult dose for Ocimum.

Mechanism of action

The pharmacological effects of Ocimum are primarily attributed to its essential oil constituents, such as eugenol, linalool, and other phenolic compounds. These compounds exert their effects through the modulation of various signaling pathways, including the inhibition of pro-inflammatory cytokines and the promotion of antioxidant defense mechanisms. The antimicrobial properties are believed to arise from the disruption of microbial cell membranes and interference with metabolic processes.

Pharmacodynamics

Ocimum exhibits a range of pharmacodynamic properties, including anti-inflammatory, antioxidant, and antimicrobial effects. The essential oils have been shown to reduce oxidative stress and inflammation, which can be beneficial in managing conditions related to chronic inflammation. Additionally, the herb may promote digestive health by enhancing gastrointestinal motility and reducing symptoms of dyspepsia.

Pharmacokinetics

The pharmacokinetics of Ocimum's active constituents vary, but generally, essential oils are readily absorbed through the gastrointestinal tract and metabolized in the liver. The bioavailability of these compounds can be influenced by the method of preparation (e.g., fresh, dried, or extract form) and the presence of other food components. The elimination half-life is also variable and dependent on the specific compounds involved.

Pregnancy

Limited data is available on the safety of Ocimum during pregnancy. It is advisable to use with caution and consult a healthcare provider.

Breast-feeding

Due to lack of sufficient evidence, it is recommended to consult a healthcare provider before use during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Essential oil
• Dried leaves
• Tincture
• Powder

Indications

• Wound healing
• Oral health (e.g., gingivitis, mouth ulcers)
• Anti-inflammatory conditions
• Gastrointestinal disorders (e.g., dyspepsia)
• Antimicrobial applications

Dosage

Children: Refer to established herbal guidelines as specific dosing information may vary based on preparation and condition being treated.

Adults: Refer to established herbal guidelines as specific dosing information may vary based on preparation and condition being treated.

Mechanism of action

The active compounds in officinale, such as resins and essential oils, exhibit their effects through various mechanisms, including the inhibition of pro-inflammatory cytokines and modulation of immune responses. These actions contribute to its analgesic and antimicrobial properties, making it beneficial in treating wounds and oral infections.

Pharmacodynamics

Myrrh has demonstrated a range of pharmacodynamic effects, including analgesia, anti-inflammatory activity, and antimicrobial action. The resin contains various terpenoids and phenolic compounds, which interact with biological pathways to exert these effects. Studies suggest that myrrh may inhibit the growth of certain bacteria and fungi, as well as reduce inflammation by blocking the synthesis of pro-inflammatory mediators.

Pharmacokinetics

The pharmacokinetics of myrrh are not well-defined due to variability in preparation and formulation. However, it is generally believed that the compounds are absorbed through the gastrointestinal tract when ingested, with some components potentially being metabolized in the liver. The onset of action may vary depending on the method of administration, with topical applications likely providing localized effects.

Pregnancy

Safety during pregnancy has not been established; consult a healthcare provider before use.

Breast-feeding

Consult a healthcare provider before using, as safety during breastfeeding is not well established.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Uncomplicated malaria caused by Plasmodium falciparum

Dosage

Children: Refer to the BNF for Children for appropriate dosing in paediatric patients.

Adults: Refer to the BNF for specific dosing recommendations.

Mechanism of action

Piperaquine acts by interfering with the heme detoxification process in the malaria parasite. It accumulates within the food vacuole of the parasite and inhibits the conversion of toxic heme into non-toxic hemozoin. This accumulation of free heme leads to oxidative stress and cellular damage, ultimately resulting in the death of the parasite.

Pharmacodynamics

Piperaquine demonstrates a dose-dependent response in its antimalarial activity. It is effective against the asexual blood stages of Plasmodium species, with a prolonged half-life that allows for once-weekly dosing in some regimens. The drug's efficacy is influenced by the rate of parasite clearance and the patient's immune response.

Pharmacokinetics

Piperaquine is well-absorbed following oral administration, with peak plasma concentrations typically occurring within 4 to 6 hours. It has a long elimination half-life, which can range from 10 to 30 days, allowing for sustained plasma levels. The drug is metabolized in the liver and excreted primarily in the feces, with a smaller fraction eliminated in the urine. Its pharmacokinetics can be significantly affected by drug interactions, particularly those that alter hepatic metabolism.

Interactions

• grapefruit juice: Severe (increases concentration)
• mitotane: Severe (decreases concentration)
• St. John's wort: Severe (decreases concentration)
• rifampicin: Severe (decreases concentration)
• dronedarone: Unknown (increases concentration)
• cobicistat: Unknown (increases concentration)
• crizotinib: Unknown (increases concentration)
• idelalisib: Unknown (increases concentration)
• imatinib: Unknown (increases concentration)
• letermovir: Unknown (increases concentration)

Pregnancy

Consult with a healthcare professional regarding the use of piper during pregnancy.

Breast-feeding

Consult with a healthcare professional regarding the use of piper during breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• {'name': 'Piperaquine', 'class': 'Penicillins', 'molecular_formula': 'C38H36N4O4'}

Indications

• Depression
• Anxiety disorders
• Cognitive enhancement

Dosage

Children: Refer to established clinical guidelines for specific dosing information.

Adults: Refer to established clinical guidelines for specific dosing information.

Mechanism of action

Pumiliopine acts as a potent inhibitor of the reuptake of neurotransmitters such as serotonin and norepinephrine. This mechanism increases the availability of these neurotransmitters in the synaptic cleft, enhancing their action on postsynaptic receptors. Additionally, it may interact with various ion channels and receptors, contributing to its pharmacological profile.

Pharmacodynamics

Pumiliopine exhibits stimulant effects, likely due to its influence on monoaminergic systems. It may enhance mood, increase alertness, and have potential nootropic effects. The modulation of serotonin and norepinephrine pathways is associated with its potential antidepressant and anxiolytic properties, although further research is necessary to fully elucidate these effects.

Pharmacokinetics

Pumiliopine is rapidly absorbed following administration, with peak plasma concentrations typically occurring within a few hours. It is metabolized primarily in the liver through cytochrome P450 enzymes, leading to several metabolites that may also exhibit pharmacological activity. The elimination half-life is variable, often influenced by individual metabolic rates, and it is excreted mainly in urine.

Pregnancy

There is limited data on the use of pumiliopine in pregnancy. Caution is advised.

Breast-feeding

The safety of pumiliopine during breastfeeding is not well established. Caution is recommended.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Dosage

Children: Refer to traditional medicine guidelines or local herbal pharmacopoeias for dosing information.

Adults: Refer to traditional medicine guidelines or local herbal pharmacopoeias for dosing information.

Indications

• Parkinson's disease
• Adjunct therapy to levodopa in advanced Parkinson's disease

Dosage

Adults: The usual starting dose is 1 mg once daily. In some patients, the dose may be increased to a maximum of 2 mg once daily based on clinical response and tolerability.

Mechanism of action

Rasagiline inhibits the enzyme monoamine oxidase type B (MAO-B), which is responsible for the breakdown of dopamine in the brain. By preventing the degradation of dopamine, rasagiline enhances dopaminergic neurotransmission, leading to improved motor function and reduced symptoms of Parkinson's disease.

Pharmacodynamics

Rasagiline exhibits a dose-dependent increase in striatal dopamine levels, which correlates with its efficacy in alleviating symptoms of Parkinson's disease. Its selective action on MAO-B, as opposed to MAO-A, minimizes the risk of adverse effects associated with the breakdown of other monoamines such as norepinephrine and serotonin.

Pharmacokinetics

Rasagiline is well absorbed after oral administration, with peak plasma concentrations occurring approximately 0.5 to 1 hour post-dose. It undergoes extensive hepatic metabolism, primarily via CYP1A2, producing active metabolites such as 1-(R)-aminoindan. The elimination half-life of rasagiline is about 3 hours, but its clinical effects may last longer due to its irreversible action on MAO-B. The drug is primarily excreted as metabolites in urine.

Contra-indications

• Hypersensitivity to rasagiline or any of its excipients
• Concomitant use of other monoamine oxidase inhibitors (MAOIs)
• Severe liver impairment
• Pheochromocytoma

Adverse effects

• Hypertensive crisis
• Dizziness
• Nausea
• Insomnia
• Headache
• Dry mouth
• Constipation
• Hallucinations
• Serotonin syndrome

Interactions

• rasagiline+methylphenidate: Severe (increases risk of hypertensive crisis)
• givosiran+rasagiline: Moderate (increases exposure)
• axitinib+rasagiline: Unknown (increases exposure)
• mexiletine+rasagiline: Unknown (increases exposure)
• rasagiline+opioids: Unknown (increases risk of adverse effects)
• rasagiline+pethidine: Unknown (increases risk of adverse effects)
• osilodrostat+rasagiline: Unknown (increases exposure)
• rucaparib+rasagiline: Unknown (increases exposure)
• vemurafenib+rasagiline: Unknown (increases exposure)

Precautions

• Monitor blood pressure regularly, especially during treatment initiation or dosage adjustments
• Use with caution in patients with a history of hypertension or cardiovascular disease
• Caution advised in patients with liver impairment
• Avoid concurrent use of sympathomimetic agents

Pregnancy

Safety in pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is unknown whether rasagiline is excreted in human milk. Caution is advised.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

• Tablets: 1 mg

Dosage

Children: Specific dosing information for paediatric patients is not available. It is advisable to consult paediatric dosing guidelines or healthcare professionals for appropriate dosing recommendations.

Adults: Specific dosing information for adults is not available. It is recommended to refer to clinical guidelines or consult a healthcare professional for appropriate dosing recommendations.

Mechanism of action

The exact mechanism of action of Sanctum is currently unclear. However, it may involve modulation of specific biochemical pathways or receptors that influence physiological processes related to its therapeutic effects. Further studies are needed to elucidate its pharmacological properties.

Pharmacodynamics

Pharmacodynamics of Sanctum may involve interactions with cellular receptors or enzymes that lead to altered cellular functions. These interactions could affect various biological systems, potentially resulting in therapeutic outcomes. The specific pharmacodynamic profile remains to be characterized.

Pharmacokinetics

The pharmacokinetic properties of Sanctum, including absorption, distribution, metabolism, and excretion, have not been well-defined in the literature. It is essential to conduct comprehensive studies to determine how the drug behaves in the body and its potential impact on therapeutic effectiveness.

Indications

• Pain relief
• Anti-inflammatory treatment
• Antimicrobial activity
• Antioxidant support
• Potential use in neurological disorders

Dosage

Children: Refer to specific guidelines for each solanum species or preparation, as dosing can vary widely.

Adults: Refer to specific guidelines for each solanum species or preparation, as dosing can vary widely.

Mechanism of action

The mechanism of action for solanum species depends on the specific compounds present in each species. For instance, alkaloids found in some Solanum species may interact with neurotransmitter systems, potentially affecting cholinergic, dopaminergic, and serotonin pathways. Other compounds may exert antioxidant effects or influence inflammatory pathways, contributing to potential therapeutic effects.

Pharmacodynamics

The pharmacodynamics of solanum species are largely determined by their active constituents, such as alkaloids and flavonoids, which can exhibit a range of effects, including anti-inflammatory, analgesic, and antimicrobial properties. The specific effects and their intensity can vary based on the species and preparation used.

Pharmacokinetics

Pharmacokinetics of solanum compounds can vary significantly based on the specific plant species and preparation method. Generally, bioactive compounds may be absorbed through the gastrointestinal tract, metabolized in the liver, and excreted via urine or feces. The half-life and bioavailability can differ, influencing the dosing and therapeutic efficacy of the extracts.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Neurological symptoms (in cases of toxicity)

Precautions

• Use with caution in individuals with known allergies to nightshade family members
• Monitor for signs of toxicity, especially when used in higher doses
• Avoid use in children without medical supervision due to potential for adverse effects

Pregnancy

Safety during pregnancy has not been established. Use only if clearly needed and prescribed by a healthcare provider.

Breast-feeding

Caution is advised as safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from light and moisture. Keep out of reach of children.

Formulations

• Dried leaves
• Powdered extracts
• Tinctures

Indications

• Pain relief
• Inflammatory disorders
• Infections

Dosage

Children: Refer to relevant herbal guidelines or consult a healthcare provider for appropriate dosing.

Adults: Refer to relevant herbal guidelines or consult a healthcare provider for appropriate dosing.

Mechanism of action

The exact mechanism of action of tamala is not well-defined in scientific literature. However, it is thought to exert its effects through modulation of inflammatory pathways, possibly by inhibiting the production of pro-inflammatory cytokines or by stabilizing cell membranes, which may reduce inflammation and pain.

Pharmacodynamics

Tamala may exhibit pharmacodynamic effects through its active components that interact with various biological targets. These interactions can lead to analgesic and anti-inflammatory effects, helping alleviate symptoms associated with pain and inflammation. The full scope of its pharmacodynamics is not well-characterized, and further research is needed to clarify its actions.

Pharmacokinetics

Pharmacokinetic data specific to tamala is limited. However, like many herbal remedies, it is likely to be absorbed in the gastrointestinal tract, metabolized in the liver, and excreted via the kidneys. The bioavailability, half-life, and other pharmacokinetic parameters require further investigation to establish a comprehensive profile.

Pregnancy

There is insufficient data on tamala use during pregnancy. Caution is advised.

Breast-feeding

Tamala is not recommended during breastfeeding due to potential risks to the infant.

Storage

Store at room temperature, away from moisture and direct sunlight.

Indications

• Asthma
• Chronic bronchitis
• Cough
• Respiratory tract infections

Dosage

Children: Refer to relevant clinical guidelines and herbal medicine references for appropriate dosing information.

Adults: Refer to relevant clinical guidelines and herbal medicine references for appropriate dosing information.

Mechanism of action

The mechanism of action of vasicine involves the inhibition of inflammatory mediators and the relaxation of bronchial smooth muscle. This results in bronchodilation, which helps alleviate symptoms of bronchospasm. Additionally, vasicine has been shown to possess antitussive properties, reducing cough and promoting the expulsion of mucus from the respiratory tract.

Pharmacodynamics

Vasica exhibits anti-inflammatory, bronchodilator, and expectorant effects. Its active compounds facilitate the relaxation of the bronchial muscles, enhance mucociliary clearance, and suppress cough reflexes. The pharmacological actions contribute to improved airway patency and respiratory function in patients with obstructive airway diseases.

Pharmacokinetics

The pharmacokinetics of vasicine include its absorption, distribution, metabolism, and excretion, though specific data on its pharmacokinetic profile are limited. Vasicine is likely absorbed through the gastrointestinal tract and may undergo hepatic metabolism. Its elimination half-life and specific metabolic pathways have not been extensively studied, warranting further research to fully elucidate these aspects.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Vomiting
• Headache
• Allergic reactions

Precautions

• Monitor for allergic reactions in patients with a history of hypersensitivity
• Use with caution in patients with gastrointestinal disorders

Pregnancy

Safety during pregnancy has not been established. Use only if clearly needed and after assessing risks versus benefits.

Breast-feeding

It is unknown whether vasica is excreted in human milk. Caution is advised when administering to breastfeeding women.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral tablets
• Liquid extract
• Syrup

Indications

• Anti-inflammatory conditions
• Pain management
• Fever reduction
• Antimicrobial treatment

Dosage

Children: Dosage in children should be determined by a healthcare provider, taking into consideration age, weight, and specific condition.

Adults: Dosage varies based on the formulation and condition being treated. Refer to specific herbal preparation guidelines or consult a healthcare provider.

Mechanism of action

The mechanism of action of Xanthocarpum is not fully understood, but it is believed that the active phytochemicals may exert their effects through modulation of inflammatory pathways and inhibition of cyclooxygenase and lipoxygenase enzymes. These actions can lead to a reduction in pain and inflammation, as well as possible antipyretic effects by influencing the hypothalamic heat-regulating center.

Pharmacodynamics

Xanthocarpum displays a range of pharmacodynamic effects, including anti-inflammatory and analgesic properties. The flavonoids found in the plant may have antioxidant effects, scavenging free radicals and reducing oxidative stress. Additionally, the plant may exhibit potential antimicrobial activity, contributing to its traditional use in treating infections.

Pharmacokinetics

The pharmacokinetics of Xanthocarpum are not well documented. However, it is generally understood that the absorption, distribution, metabolism, and excretion of phytochemicals can vary widely based on their chemical structures and the formulation used. Bioavailability may be influenced by factors such as the presence of other compounds in herbal preparations and individual patient characteristics.

Pregnancy

The safety of xanthocarpum during pregnancy has not been established. It is advisable to avoid use unless clearly needed.

Breast-feeding

The excretion of xanthocarpum in human milk is unknown. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Nausea and vomiting associated with motion sickness
• Nausea in pregnancy (morning sickness)
• Post-operative nausea and vomiting
• Osteoarthritis and other inflammatory joint conditions
• Dyspepsia and gastrointestinal discomfort

Dosage

Children: Refer to established guidelines and consult a healthcare professional for appropriate dosing based on formulation and indication.

Adults: Refer to established guidelines and consult a healthcare professional for appropriate dosing based on formulation and indication.

Mechanism of action

Ginger contains bioactive compounds, including gingerol and shogaol, which exhibit anti-inflammatory and antioxidant effects. The mechanism of action involves the inhibition of pro-inflammatory cytokines and enzymes, such as cyclooxygenase and lipoxygenase, leading to reduced inflammation. Ginger also enhances gastrointestinal motility and may exert a protective effect on the gastric mucosa.

Pharmacodynamics

The pharmacodynamic effects of ginger are primarily attributed to its active constituents, which modulate various physiological pathways. Gingerol and shogaol have been shown to influence the release of serotonin and other neurotransmitters, thereby alleviating nausea. Additionally, ginger's antioxidant properties help to mitigate oxidative stress in cells, contributing to its anti-inflammatory effects.

Pharmacokinetics

Ginger is rapidly absorbed in the gastrointestinal tract, with peak plasma concentrations of its active compounds occurring within 1-2 hours after ingestion. The bioavailability of gingerol and shogaol can be affected by the formulation and method of preparation (e.g., fresh, dried, or as an extract). The elimination half-life of these compounds is variable, with metabolism occurring primarily in the liver. They are excreted through urine and bile, and their effects can last for several hours.

Adverse effects

• Gastrointestinal discomfort
• Heartburn
• Nausea
• Diarrhea
• Skin irritation

Interactions

• Anticoagulants (e.g., warfarin)
• Antidiabetic medications
• Antihypertensive medications

Precautions

• Use with caution in patients with gallstones
• May affect blood sugar levels; monitor in diabetic patients
• May increase the risk of bleeding when used with anticoagulants

Pregnancy

Zingiber (ginger) is generally considered safe in food amounts during pregnancy. However, high doses should be avoided due to potential risks.

Breast-feeding

Zingiber is likely safe in food amounts while breastfeeding, but high doses should be avoided.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Dried root
• Powder
• Capsules
• Tinctures
• Essential oil

Mechanism of action

Exposure to low temperatures often causes allergic responses or urticaria. Similarly, menthol, a common food additive is also known to cause urticaria, asthma, and rhinitis. However, despite the obvious clinical implications, the molecular mechanisms responsible for inducing allergic responses to low temperatures and menthol have not been determined. Because a non-selective cation channel, transient receptor potential subtype M8 (TRPM8) is activated by cold and menthol, we hypothesized that this channel mediates cold- and menthol-induced histamine release in mast cells. Here, we report that TRPM8 is expressed in the basophilic leukemia mast cell line, RBL-2H3, and that exposure to menthol or low temperatures induced Ca(2+) influx in RBL-2H3 cells, which was reversed by a TRPM8 blocker. Furthermore, menthol, a TRPM8 agonist, induced the dose-dependent release of histamine from RBL-2H3 cells. When TRPM8 transcripts were reduced by siRNA (small interfering RNA), menthol- and cold-induced Ca(2+) influx and histamine release were significantly reduced. In addition, subcutaneous injection of menthol evoked scratching, a typical histamine-induced response which was reversed by a TRPM8 blocker. Thus, our findings indicate that TRPM8 mediates the menthol- and cold-induced allergic responses of mast cells, and suggest that TRPM8 antagonists be viewed as potential treatments for cold- and menthol-induced allergies. /DL-Menthol/ Menthol's characteristic cooling sensation is due, in part, to the activation of sensory neurons generally termed transient receptor potential (TRP) channels, in particular transient receptor potential melastatin family member 8 (TRPM8) and transient receptor potential subfamily A, member 1 (TRPA1). Menthol acts upon TRPM8 receptors by rapidly increasing intracellular calcium and mobilizing calcium flux through the channels to induce cold response signals at the application site. Aside from its cold-inducing sensation capabilities, menthol exhibits cytotoxic effects in cancer cells, induces reduction in malignant cell growth, and engages in synergistic excitation of GABA receptors and sodium ion channels resulting in analgesia. /DL-Menthol/ In recent years, the transient receptor potential melastatin member 8 (TRPM8) channel has emerged as a promising prognostic marker and putative therapeutic target in prostate cancer. We have found that forced overexpression of TRPM8 in PC-3 cells can inhibit the cell proliferation and motility probably through the TRPM8 activation. In this study, we aimed to investigate whether activating the TRPM8 channel by its selective agonist menthol can inhibit the proliferation and motility of androgen-independent prostate cancer (AIPC) with remarkable expression of TRPM8. Menthol is a naturally occurring compound, which has been widely used in cosmetics and pharmaceutical products, and also as flavoring in food. DU145 cells are androgen-independent but have a remarkable expression of TRPM8. The demonstration of the existence of TRPM8 and the absence of TRPA1 in DU145 cells provided the foundation for the following experiments, because both TRPM8 and TRPA1 are molecular targets of menthol. The outcome of MTT assay indicated that menthol inhibited the cell growth (p < 0.01). Cell cycle distribution and scratch assay analysis revealed that menthol induced cell cycle arrest at the G(0)/G(1) phase (p < 0.01). Furthermore, menthol inhibited the migration of DU145 cells by downregulating the focal-adhesion kinase. So it suggests that the activation of the existing TRPM8 channels may serve as a potential and pragmatic treatment for those AIPC with remarkable expression of TRPM8, and menthol is a useful compound for future development as an anticancer agent. /DL-Menthol/